Keep Informed on Legal and Compliance Developments Affecting Diagnostic Labs
Best practices and expert insight to help lab professionals comply with regulations and identify strategic trends in business and technology
Already a Subscriber? Log in Here
Lab Industry Advisor Subscription
Struggling with Staying Informed? In the fast-paced world of diagnostic medicine, staying updated with the latest legal, compliance, regulatory, and industry insights is crucial. Yet, finding reliable and comprehensive information can be overwhelming and time-consuming.
Lab Industry Advisor to the Rescue! Lab Industry Advisor provides comprehensive, up-to-date insights and analyses tailored to your needs. With expert commentary and actionable advice, you’ll stay ahead of the curve. No more sifting through endless sources—everything you need is right here!
Start your free trial today and see how Lab Industry Advisor can transform your approach. Get instant access to invaluable resources designed to keep you informed and competitive. Explore detailed reports, in-depth articles, and exclusive industry insights that help you make better decisions faster. Choose from three subscription levels tailored to fit your needs: Essential, Premium, and Elite.
Additional Business Intelligence Offerings
Clinical Diagnostics Insider
Keeps you up-to-date on new diagnostic tests, testing trends and opportunities, and emerging test technologies
Virtual Events & Webinars
Virtual events & webinars offer a variety of solutions and strategies for dealing with key issues labs face.
Lab Industry Advisor Subscriptions Include
Analysis and insight on key compliance, legal, and business developments affecting laboratories
- Updates on changes to regulations
- Healthcare-related laws
- FDA approvals
- Business deals in the diagnostics space, and more
Latest Articles
LDTs Rule Update: More Support for Legal Challenges Against FDA
Key clinical laboratory organizations file amicus brief, reiterating that the FDA is overstepping its authority, and its new rule would cause “irreparable patient harm”
New FDA LDTs Guidance Offers Useful Summary, But Questions Remain
Recently released document for small labs offers a more digestible version of the final rule requirements but still lacks key details
CMS Slated to Close Change Healthcare Payment Program
Program meant to ease cash flow disruptions experienced by some Medicare providers and suppliers due to the cyberattack will conclude in mid-July
Medicare to Cover Over-the-Counter COVID-19 Tests
...
Register
CMS Restores Medicare Coverage of Certain Genetic Thyroid Cancer Tests
...
Register
New Special Prosecutor to Crack Down on COVID-19 Relief Fraud
Weeks after the COVID-19 public health emergency was declared, Congress passed a pair of massive bills—the Families First Coronavirus Response Act (FFCRA) and Coronavirus Aid, Relief, and Economic Security Act (CARES)—providing trillions of dollars in relief for...
Certain Gut Microbes May Identify Pancreatic Cancer Sooner
A specific panel of gut microbes may identify pancreatic cancer, irrespective of how far the disease has progressed, suggests research published online in the journal Gut. The findings offer hope of a new non-invasive method of diagnosing this hard to treat...
The Latest Changes at G2 Intelligence
It’s been busy here at G2 Intelligence as we continue to make improvements to the brand. One change that you’ve likely noticed is that our four monthly briefings—National Lab Reporter, Diagnostic Testing & Emerging Technologies, Lab Compliance Advisor, and...
Labcorp and Walgreens Partner to Provide Free COVID-19 Test Kits
On March 7, global life science company Labcorp and major US retailer Walgreens announced that Labcorp’s Pixel by Labcorp® COVID-19 at-home collection kit will be available at Walgreens locations across the US for free to eligible individuals. The PCR test has...
COVID-19 Revenues Bubble Hasn’t Burst, But It Is Leaking
What a difference a year makes. In Q4 2021, COVID-19 testing demand was cresting and lab companies with COVID-19 products were posting record—and ultimately unsustainable—revenue growth. Compared to this baseline, 15 of the 31 companies that had reported their...
Blue Cross and Blue Shield of Minnesota Files Lawsuit Against GS Labs
EAGAN, MN — Blue Cross and Blue Shield of Minnesota (Blue Cross) announced on March 1 that it is taking legal action against COVID-19 testing laboratory GS Labs, LLC (GS Labs) to recover more than $10 million in overpayments made since the start of the pandemic....
Be ‘Recall Ready,’ FDA Urges Companies
SILVER SPRING, MD — On March 3, the U.S. Food and Drug Administration finalized guidance to help companies prepare to quickly and effectively remove violative products from the market. The guidance describes steps companies should take, before a recall is...
Labs in Court Weekly Roundup
Court cases involving the lab and health care industries from this past week and a half have centered mostly on fraud. In addition to those cases, a former doctor was charged for unlawfully distributing opioid pills and the U.S. Department of Justice (DOJ) and...
